Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 766.8 | 641.9 | 454.1 | 497.1 |
| Revenue growth | 19.5% | 41.4% | -8.7% | |
| Cost of goods sold | 433.1 | 336.2 | 241.9 | 242.6 |
| Gross profit | 333.7 | 305.6 | 212.2 | 254.5 |
| Gross margin | 43.5% | 47.6% | 46.7% | 51.2% |
| Selling, general and administrative | 175.5 | 198.7 | 122.6 | 147.2 |
| Research and development | 25.1 | 21.2 | 19.7 | 23.6 |
| EBITA | 128.7 | 81.1 | 62.8 | 75.0 |
| EBITA margin | 16.8% | 12.6% | 13.8% | 15.1% |
| Amortization of intangibles | 68.7 | 77.5 | 84.1 | 85.2 |
| EBIT | 60.0 | 3.6 | -21.3 | -10.2 |
| EBIT margin | 7.8% | 0.6% | -4.7% | -2.0% |
| Pre-tax income | 28.1 | -29.0 | -63.9 | -58.5 |
| Income taxes | 8.7 | -10.5 | -11.6 | -11.8 |
| Tax rate | 31.0% | 36.1% | 18.1% | 20.2% |
| Net income | 19.4 | -18.5 | -52.3 | -46.7 |
| Net margin | 2.5% | -2.9% | -11.5% | -9.4% |
| |
| Diluted EPS | $0.20 | ($0.21) | ($0.59) | ($0.53) |
| Shares outstanding (diluted) | 98.9 | 90.2 | 88.3 | 88.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|